Cargando…

A MicroRNA Signature Predicts Survival in Early Stage Small-Cell Lung Cancer Treated with Surgery and Adjuvant Chemotherapy

Small-cell lung cancer (SCLC) is one of the most aggressive cancers, yet the molecular mechanisms underlying its devastating clinical outcome remain elusive. In this study, we investigated whether microRNA (miRNA) expression profiles can predict the clinical outcomes of SCLC patients. A total of 82...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bi, Nan, Cao, Jianzhong, Song, Yongmei, Shen, Jie, Liu, Wenyang, Fan, Jing, He, Jie, Shi, Yuankai, Zhang, Xun, Lu, Ning, Zhan, Qimin, Wang, Luhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3956664/ https://www.ncbi.nlm.nih.gov/pubmed/24637927 http://dx.doi.org/10.1371/journal.pone.0091388

Ejemplares similares

Molecular predictors of brain metastasis-related microRNAs in lung adenocarcinoma
por: Sun, Guogui, et al.
Publicado: (2019)

Correction: Molecular predictors of brain metastasis-related microRNAs in lung adenocarcinoma
por: Sun, Guogui, et al.
Publicado: (2020)

Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients
por: Ji, Dengbo, et al.
Publicado: (2018)

MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma
por: Liu, Lipin, et al.
Publicado: (2017)

MiR-423-5p in brain metastasis: potential role in diagnostics and molecular biology
por: Sun, Guogui, et al.
Publicado: (2018)

Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging
por: Xu, Jing, et al.
Publicado: (2016)

MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II
por: Dhayat, Sameer Abdallah, et al.
Publicado: (2015)

Adjuvant Chemotherapy Improves Survival for Children With Massive Choroidal Invasion of Retinoblastoma
por: Feng, Zhao Xun, et al.
Publicado: (2023)

A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer
por: Okuno, Keisuke, et al.
Publicado: (2023)

Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer
por: Bao, Siqi, et al.
Publicado: (2021)

Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non‐small cell lung cancer
por: Zhang, Pei, et al.
Publicado: (2020)

Plasma extracellular vesicle microRNA profiling and the identification of a diagnostic signature for stage I lung adenocarcinoma
por: Gao, Shugeng, et al.
Publicado: (2021)

A MicroRNA Expression Signature In Taxane-anthracycline-based Neoadjuvant Chemotherapy Response
por: Zheng, Yi, et al.
Publicado: (2015)

A novel three-microRNA signature for predicting survival in patients with nasopharyngeal carcinoma
por: Zhang, Shan-Qiang, et al.
Publicado: (2022)

Expression signatures and roles of microRNAs in inflammatory breast cancer
por: Qi, Yihang, et al.
Publicado: (2019)

Adjuvant chemotherapy for early-stage cervical cancer
por: Asano, Hiroshi, et al.
Publicado: (2016)

Adjuvant Chemotherapy for Stage III Colon Cancer
por: Taieb, Julien, et al.
Publicado: (2020)

Adjuvant Chemotherapy for Stage II Colon Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2020)

Circulating microRNA signature for the diagnosis of childhood dilated cardiomyopathy
por: Jiao, Meng, et al.
Publicado: (2018)

Molecular Signature of Aluminum Hydroxide Adjuvant in Ovine PBMCs by Integrated mRNA and microRNA Transcriptome Sequencing
por: Varela-Martínez, Endika, et al.
Publicado: (2018)

A network-based predictive gene-expression signature for adjuvant chemotherapy benefit in stage II colorectal cancer
por: Cao, Bangrong, et al.
Publicado: (2017)

Serum microRNA signatures and metabolomics have high diagnostic value in hepatocellular carcinoma
por: Liu, Hai-Ning, et al.
Publicado: (2017)

Prognostic value of a hypoxia-related microRNA signature in patients with colorectal cancer
por: Yang, Yongmei, et al.
Publicado: (2020)

The Role of MicroRNA Signature as Diagnostic Biomarkers in Different Clinical Stages of Colorectal Cancer
por: Eslamizadeh, Sara, et al.
Publicado: (2018)

Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy
por: Dalmasso, Bruna, et al.
Publicado: (2018)

Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
por: Lee, Mok-Won, et al.
Publicado: (2021)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer
por: Chung, Young Shin, et al.
Publicado: (2017)

Construction of a Nine-MicroRNA-Based Signature to Predict the Overall Survival of Esophageal Cancer Patients
por: Zhang, Xiaobin, et al.
Publicado: (2021)

Serum microRNA signatures and metabolomics have high diagnostic value in gastric cancer
por: Liu, Hai-Ning, et al.
Publicado: (2018)

Adjuvant and first line chemotherapy use for endometrial cancer
por: Knisely, Anne, et al.
Publicado: (2022)

A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients
por: Lu, Jia-huan, et al.
Publicado: (2018)

An Integrated mRNA and microRNA Expression Signature for Glioblastoma Multiforme Prognosis
por: Xiong, Jie, et al.
Publicado: (2014)

Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study
por: Gao, Peng, et al.
Publicado: (2018)

A Prehepatectomy Circulating Exosomal microRNA Signature Predicts the Prognosis and Adjuvant Chemotherapeutic Benefits in Colorectal Liver Metastasis
por: Wang, Yun, et al.
Publicado: (2021)

Development and validation of a prediction model using molecular marker for long‐term survival in unresectable stage III non‐small cell lung cancer treated with chemoradiotherapy
por: Yang, Yufan, et al.
Publicado: (2021)

Survival and time to initiation of adjuvant chemotherapy among breast cancer patients: a systematic review and meta-analysis
por: Zhan, Qiao-Hui, et al.
Publicado: (2017)

Construction of prognostic microRNA signature for human invasive breast cancer by integrated analysis
por: Shi, Wei, et al.
Publicado: (2019)

A Ten-microRNA Expression Signature Predicts Survival in Glioblastoma
por: Srinivasan, Sujaya, et al.
Publicado: (2011)

A novel microRNA signature predicts survival in stomach adenocarcinoma
por: Ding, Bowen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ou2dui3jtc67nvbp09vv5h52pa